Skip to content

Virtual Mindfulness and Weight Management to Mitigate Risk of Relapse and Improve Wellbeing in Cancer Survivors

A Virtual Mindfulness and Weight Management Program for Those With Cancer Histories to Mitigate Risk of Relapse and Improve Wellbeing: A Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06030427
Enrollment
19
Registered
2023-09-11
Start date
2023-09-08
Completion date
2024-01-02
Last updated
2025-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm, Obesity-Related Malignant Neoplasm

Brief summary

This clinical trial tests how well a virtual mindfulness and weight management program to mitigate risk of relapse and improve well being for obese cancer survivors in community practice and rural areas. Obesity has been linked to increased risk for certain kinds of cancer and is the second highest modifiable risk factor for cancer. It is also well documented that having a cancer diagnosis and treatment is a stressful experience. It is hoped that an addition of a 10-minute mindfulness-based stress reduction exercise to the virtual positive health habits group focused on weight management can improve wellbeing and distress. Virtual care options continue to extend the reach of medical providers to cancer survivors, particularly those in the rural setting. A virtual behavioral weight management program with an integrated mindfulness component may improve mood, coping strategies, stress management, and weight loss among community practice and rural obese cancer survivors.

Detailed description

PRIMARY OBJECTIVES: I. To assess if a 12-week virtual weight management program with a mindfulness component will improve well-being of obese cancer patients with a specific focus on self-reported measures of depression and anxiety. II. To assess if a mindfulness component added to the virtual behavioral weight management will promote weight loss, improve mood, and increase physical activity. OUTLINE: Patients participate in a virtual behavioral weight management program with an integrated mindfulness component consisting of 12, 75-minute virtual group sessions over 12 weeks to help improve mood, coping strategies, stress management, and weight loss. Patents also receive patient education handouts, view behavioral educational PowerPoint presentations over 30 minutes, and wear a Fitbit on study.

Interventions

BEHAVIORALBehavioral Dietary Intervention

Participate in weight management program

OTHEREducational Intervention

Receive patient education handouts

OTHERHealth Promotion and Education

View behavioral educational PowerPoint presentation

OTHERInternet-Based Intervention

Complete virtual behavioral weight management with an integrated mindfulness component program

OTHERInterview

Ancillary studies

OTHERMedical Device Usage and Evaluation

Wear Fitbit

Complete mindfulness components

OTHERPhysical Performance Testing

Ancillary studies

OTHERQuestionnaire Administration

Ancillary studies

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 or over * Identified stage I, II, or III cancer in remission * Body mass index (BMI) of 30 or greater * English as a primary language * Has access to a device with a camera (computer, tablet, or video capable phone) that has wifi and reliable internet access

Exclusion criteria

* Unable to provide consent * Eastern Cooperative Oncology Group (ECOG) performance status scale score of 3 or above

Design outcomes

Primary

MeasureTime frameDescription
General anxiety disorder-7 (GAD-7)Baseline; 12 weeksAssessed by change in GAD-7 scores from a total score for seven items ranges from 0 to 21: 0-4 (minimal anxiety); 5-9 (mild anxiety); 10-14 (moderate anxiety); 15-21 (severe anxiety).
Patient Health Questionnaire (PHQ)-8Baseline; 12 weeksAssessed by change in PHQ-8 scores, as measured by a total score of 4 items from 0-12: 0-2 (normal); 3-5 (mild depression); 6-8 (moderate depression); 9-12 (severe depression).
Feasibility of virtual mindfulness and weight management program12 weeksAssessed by the extent to which participants adhere to the intervention. Will be quantified based on number of sessions attended out of a possible 12.

Secondary

MeasureTime frameDescription
Body composition parameterBaseline; 12 weeksWill be assessed in a fasted state or 3 hour post meal by subjects standing on a scale without socks or shoes.
Daily activity levels - activityBaseline; 12 weeksWill be assessed from data recorded by a wrist-worn accelerometer monitoring fitness activity.
Body weightBaseline; 12 weeksAssessed by change in body weight
Daily activity levels - heart rateBaseline; 12 weeksWill be assessed by heart rate monitoring as recorded by a wrist-worn accelerometer (Fitbit Inspire)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026